NLRP3 and rheumatoid arthritis: The present study revealed the therapeutic potential of IOP in treating RA, demonstrating its ability to modulate key inflammatory pathways, including the NF-κB and NLRP3 inflammasome pathways, using CIA and MH7A cell models (Figure 8).